First City Capital Management’s AstraZeneca AZN Stock Holding History

First City Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Sell	3,619 -25	-0.7%	-$4.7K	0.33%	78
2026 Q1	$719K	Sell	3,644 -250	-6%	-$48.2K	0.38%	71
2025 Q4	$716K	Hold	3,894	–	–	0.38%	71
2025 Q3	$597K	Sell	3,894 -163	-4%	-$24.7K	0.32%	79
2025 Q2	$567K	Hold	4,057	–	–	0.33%	76
2025 Q1	$596K	Hold	4,057	–	–	0.36%	71
2024 Q4	$532K	Sell	4,057 -100	-2%	-$14K	0.28%	86
2024 Q3	$648K	Hold	4,157	–	–	0.33%	73
2024 Q2	$648K	Sell	4,157 -936	-18%	-$141K	0.36%	66
2024 Q1	$690K	Hold	5,093	–	–	0.38%	64
2023 Q4	$686K	Hold	5,093	–	–	0.4%	69
2023 Q3	$690K	Hold	5,093	–	–	0.43%	64
2023 Q2	$729K	Sell	5,093 -711	-12%	-$105K	0.43%	64
2023 Q1	$850K	Sell	5,804 -1	-0%	-$135	0.5%	56
2022 Q4	$787K	Sell	5,805 -617	-10%	-$77.4K	0.47%	61
2022 Q3	$704K	Sell	6,422 -50	-0.8%	-$6.34K	0.46%	61
2022 Q2	$855K	Hold	6,472	–	–	0.53%	55
2022 Q1	$859K	Hold	6,472	–	–	0.47%	57
2021 Q4	$721K	Sell	6,472 -500	-7%	-$58.8K	0.41%	71
2021 Q3	$837K	Hold	6,972	–	–	0.47%	63
2021 Q2	$801K	Buy	6,972 +157	+2%	+$17.2K	0.44%	66
2021 Q1	$743K	Sell	6,815 -305	-4%	-$30.7K	0.43%	71
2020 Q4	$713K	Sell	7,120 -9,072	-56%	-$961K	0.46%	70
2020 Q3	$1.72M	Buy	16,192 +7,152	+79%	+$795K	0.64%	49
2020 Q2	$956K	Buy	9,040 +462	+5%	+$47.7K	0.73%	44
2020 Q1	$766K	Hold	8,578	–	–	0.75%	45
2019 Q4	$855K	Buy	8,578 +113	+1%	+$10.6K	0.59%	60
2019 Q3	$755K	Sell	8,465 -850	-9%	-$73.7K	0.55%	63
2019 Q2	$769K	Hold	9,315	–	–	0.56%	60
2019 Q1	$753K	Hold	9,315	–	–	0.54%	63
2018 Q4	$708K	Sell	9,315 -150	-2%	-$11.7K	0.55%	64
2018 Q3	$749K	Sell	9,465 -250	-3%	-$18.9K	0.5%	71
2018 Q2	$682K	Buy	9,715 +100	+1%	+$7.19K	0.49%	68
2018 Q1	$672K	Hold	9,615	–	–	0.5%	66
2017 Q4	$667K	Hold	9,615	–	–	0.45%	70
2017 Q3	$652K	Buy	9,615 +150	+2%	+$9.48K	0.46%	69
2017 Q2	$645K	Hold	9,465	–	–	0.47%	69
2017 Q1	$589K	Sell	9,465 -32	-0.3%	-$1.86K	0.43%	72
2016 Q4	$519K	Buy	9,497 +150	+2%	+$8.52K	0.39%	77
2016 Q3	$614K	Sell	9,347 -125	-1%	-$8.17K	0.47%	67
2016 Q2	$572K	Hold	9,472	–	–	0.43%	66
2016 Q1	$533K	Buy	9,472 +1	+0%	+$60	0.36%	68
2015 Q4	$643K	Hold	9,471	–	–	0.43%	59
2015 Q3	$603K	Buy	9,471 +1	+0%	+$66	0.44%	59
2015 Q2	$603K	Buy	9,470 +30	+0.3%	+$2.05K	0.42%	61
2015 Q1	$646K	Sell	9,440 -80	-0.8%	-$5.56K	0.45%	61
2014 Q4	$670K	Hold	9,520	–	–	0.46%	59
2014 Q3	$680K	Hold	9,520	–	–	0.49%	60
2014 Q2	$707K	Sell	9,520 -287	-3%	-$20.7K	0.5%	54
2014 Q1	$636K	Hold	9,807	–	–	0.45%	60
2013 Q4	$582K	Buy	9,807 +132	+1%	+$7.17K	0.48%	67
2013 Q3	$502K	Buy	9,675 +925	+11%	+$46.5K	0.42%	77
2013 Q2	$414K	Buy	+8,750	New	+$446K	0.38%	86

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

First City Capital Management's AZN Position: Q2 2026 in Review

First City Capital Management reduced its AstraZeneca (AZN) stake by 0.69% in Q2 2026, selling an estimated $4.7K and leaving 3,619 shares worth $686K. The position accounts for 0.33% of the portfolio, ranked #78.

First City Capital Management first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.72M in Q3 2020. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

First City Capital Management held 3,619 shares of AstraZeneca worth $686K as of Q2 2026.
First City Capital Management sold 25 AstraZeneca shares in Q2 2026, an estimated $4.7K.
AstraZeneca made up 0.33% of First City Capital Management's portfolio in Q2 2026, its #78 holding.
First City Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
First City Capital Management's AstraZeneca position peaked at $1.72M in Q3 2020.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First City Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.